AV200 Fellowship

Emory Vaccine Center – AIDS Vaccine 200 Endowed Fellowship

From 2003 to 2025 the all-volunteer organization, Action Cycling Atlanta, produced the AIDS Vaccine 200 (AV200), a two-day, two-hundred mile cycling event to support HIV vaccine and cure research at the Emory Vaccine Center (EVC). Every dollar raised by the riders was donated to the beneficiaries totaling over $3 million for HIV vaccine and cure research at Emory plus an additional $1 million to support Atlanta-area AIDS service organizations.

The AV200 was more than a cycling event, it was a movement fueled by a shared mission: to end HIV/AIDS through research, education, care and community support. Since 2012, the ride supported over fifty AV200 Fellows, early career scientists at the Emory Vaccine Center with new ideas and new approaches to fighting and preventing the disease. The ride’s legacy continues until there is a vaccine and cure through the EVC-AIDS Vaccine 200 Endowed Fellowship.

With your help, the EVC-AIDS Vaccine 200 Endowed Fellowship is:

· Supporting the next generation of researchers by funding at least one annual AV200 Fellow annually to be awarded to graduate or postdoctoral researchers dedicated to HIV vaccine development, prevention and cure.

· Funding innovative project that advance global efforts to end the HIV/AIDS epidemic.

· Honoring the AV200 community’s commitment to creating a world without AIDS, ensuring that the passion and dedication of the riders, volunteers and supporters have a lasting impact.

The endowed fund provides annual income for one purpose: to support the research of the next generation of HIV vaccine and cure scientists at the Emory Vaccine Center. The greater the fund’s size, the larger the award. With your help the fund will support multiple research awards annually.

Now more than ever, your support is necessary to grow this fund and increase the funding for HIV vaccine and cure research.

GIVE NOW

For more information about the fund or about leaving the EVC-AIDS Vaccine 200 Endowed Fellowship in your estate plans, please contact Jonathan Russell.

The fight against HIV/AIDS is far from over!

· Over 38 million people globally are living with HIV/AIDS.

· New infections continue to occur in the United States and around the world, making prevention efforts and vaccine and cure development more critical than ever.

· Access to care and education remains a challenge for many communities, underscoring the importance of supporting innovative research.